Toshiyuki Yoneda Selected Research

Toshiyuki Yoneda Research Topics

Disease

47	Neoplasms (Cancer) 01/2022 - 02/2002
39	Neoplasm Metastasis (Metastasis) 10/2021 - 02/2002
26	Breast Neoplasms (Breast Cancer) 07/2023 - 02/2002
23	Bone Resorption 01/2017 - 03/2002
12	Pain (Aches) 07/2023 - 04/2006
7	Rheumatoid Arthritis 11/2021 - 05/2011
6	Osteoporosis 12/2018 - 07/2010
5	Acidosis 12/2018 - 04/2006
5	Multiple Myeloma 01/2017 - 10/2004
5	Bone Diseases (Bone Disease) 03/2016 - 03/2004
4	Hypercalcemia (Milk Alkali Syndrome) 07/2010 - 10/2002
3	Osteonecrosis (Kienbock's Disease) 01/2017 - 03/2010
3	Lymphatic Metastasis 10/2015 - 09/2012
3	Melanoma (Melanoma, Malignant) 07/2011 - 02/2005
3	Metabolic Bone Diseases (Osteopenia) 03/2011 - 08/2006
2	Hypersensitivity (Allergy) 07/2023 - 02/2021
2	Prostatic Neoplasms (Prostate Cancer) 12/2018 - 05/2010
2	Squamous Cell Carcinoma of Head and Neck 10/2015 - 09/2012
2	Familial Hypophosphatemic Rickets (X-Linked Hypophosphatemia) 01/2011 - 03/2004
2	Bisphosphonate-Associated Osteonecrosis of the Jaw 07/2010 - 03/2010
2	Hypoxia (Hypoxemia) 05/2007 - 03/2007
2	Hyperalgesia 01/2007 - 11/2006
2	Ganglion Cysts (Ganglion) 01/2007 - 11/2006
2	Osteolysis 11/2006 - 10/2004
2	Lung Neoplasms (Lung Cancer) 03/2004 - 03/2002
1	Cancer Pain 03/2023
1	Hypertrophy 11/2021
1	Tongue Neoplasms (Tongue Neoplasm) 04/2014

Drug/Important Bio-Agent (IBA)

17	Diphosphonates (Bisphosphonates)IBA 01/2017 - 10/2002
13	Denosumab FDA Link 11/2021 - 06/2011
10	AcidsIBA 07/2023 - 04/2006
8	LigandsIBA 01/2020 - 08/2004
8	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 10/2013 - 02/2002
8	Zoledronic Acid (Zometa)FDA Link 09/2012 - 10/2003
7	Proteins (Proteins, Gene)FDA Link 11/2011 - 01/2007
6	Messenger RNA (mRNA)IBA 11/2014 - 11/2006
6	CytokinesIBA 10/2013 - 08/2003
5	Monoclonal AntibodiesIBA 06/2016 - 10/2004
5	Protons (Proton)IBA 10/2015 - 11/2006
5	Parathyroid Hormone-Related ProteinIBA 06/2011 - 10/2002
4	Lactic Acid (Lactate)FDA LinkGeneric 03/2023 - 01/2015
4	Receptor Activator of Nuclear Factor-kappa B (TRANCE-R)IBA 06/2016 - 08/2004
3	Transcription Factors (Transcription Factor)IBA 11/2021 - 03/2007
3	Vascular Endothelial Growth Factor CIBA 10/2015 - 09/2012
3	Dinoprostone (PGE2)FDA Link 11/2014 - 02/2006
3	N- (2- cyclohexyloxy- 4- nitrophenyl)methanesulfonamideIBA 11/2014 - 02/2006
3	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 11/2014 - 02/2006
3	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 04/2014 - 02/2006
3	Neutralizing AntibodiesIBA 12/2012 - 08/2011
3	Phosphates (Orthophosphate)IBA 07/2010 - 03/2004
3	CSK Tyrosine-Protein KinaseIBA 05/2010 - 08/2003
3	IntegrinsIBA 10/2004 - 05/2002
3	Complementary DNA (cDNA)IBA 10/2003 - 02/2002
2	Oxygen (Dioxygen)IBA 01/2022 - 05/2007
2	Antirheumatic Agents (DMARD)IBA 11/2021 - 01/2019
2	HMGB1 Protein (HMG1)IBA 02/2021 - 10/2020
2	Methotrexate (Mexate)FDA LinkGeneric 01/2019 - 06/2016
2	Proton Pumps (Proton Pump)IBA 05/2018 - 10/2015
2	bafilomycin A1IBA 05/2018 - 11/2006
2	Adenosine Triphosphatases (ATPase)IBA 01/2017 - 07/2011
2	Bone Density Conservation AgentsIBA 01/2017 - 01/2017
2	MineralsIBA 05/2013 - 07/2010
2	Tyrosine Kinase InhibitorsIBA 09/2012 - 11/2006
2	ErbB Receptors (EGF Receptor)IBA 09/2012 - 05/2007
2	Insulin-Like PeptidesIBA 08/2012 - 06/2011
2	Acid Sensing Ion ChannelsIBA 05/2011 - 11/2006
2	Collagen Type I (Type I Collagen)IBA 03/2011 - 10/2009
2	Hormones (Hormone)IBA 05/2010 - 03/2004
2	OsteoprotegerinIBA 09/2008 - 11/2006
2	Cell Adhesion MoleculesIBA 07/2008 - 05/2002
2	Tartrate-Resistant Acid PhosphataseIBA 01/2008 - 02/2005
2	CortactinIBA 05/2006 - 01/2006
2	Ibandronic Acid (Boniva)FDA Link 02/2006 - 10/2002
2	Indicators and Reagents (Reagents)IBA 03/2004 - 10/2002
1	CalciumIBA 03/2023
1	Adenosine Triphosphate (ATP)IBA 01/2022
1	Therapeutic UsesIBA 10/2021
1	5-bromo-2'-chloro-2-aminobenzophenoneIBA 02/2021
1	DNA-Binding Proteins (DNA Binding Protein)IBA 10/2020
1	Histones (Histone)IBA 10/2020
1	AndrogensIBA 12/2018
1	Analgesics (Analgesic Drugs)IBA 12/2018
1	Alkaline PhosphataseIBA 12/2018
1	Connexin 43 (Connexin43)IBA 01/2017
1	RANK LigandIBA 06/2016
1	Notch ReceptorsIBA 03/2016
1	Ion Channels (Ion Channel)IBA 10/2015
1	Fibronectins (Fibronectin)IBA 10/2015
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 11/2014
1	Epidermal Growth Factor (EGF)IBA 09/2012
1	StathminIBA 09/2012
1	Gefitinib (Iressa)FDA Link 09/2012
1	Fibroblast Growth Factors (Fibroblast Growth Factor)IBA 08/2012
1	Tyrosine (L-Tyrosine)FDA Link 08/2012
1	Insulin-Like Growth Factor I (IGF-1)IBA 08/2012
1	Teriparatide (Parathar)FDA Link 01/2012

Therapy/Procedure

6	Therapeutics 01/2019 - 08/2003
2	Drug Therapy (Chemotherapy) 12/2018 - 06/2011
1	Denervation 12/2018
1	Castration 12/2018